These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1465998)
1. Beneficial effect of intraportal syngeneic pancreatic islet transplantation after portacaval shunt in rats. Nakafusa Y; Goss JA; Roland CR; Lacy PE; Flye MW Transplant Proc; 1992 Dec; 24(6):2916. PubMed ID: 1465998 [No Abstract] [Full Text] [Related]
2. The effect of intrahepatic islet isografts on liver integrity following heterotopic auxiliary liver isotransplantation in rats. Yu W; Wan X; Wright JR; Coddington D; Bitter-Suermann H Transplant Proc; 1992 Dec; 24(6):2920-1. PubMed ID: 1466000 [No Abstract] [Full Text] [Related]
3. The influence of the implantation site (kidney capsule vs. portal vein) on islet survival. Woehrle M; Markman JF; Beyer K; Naji A; Bretzel RG; Federlin K Horm Metab Res Suppl; 1990; 25():163-5. PubMed ID: 2088960 [No Abstract] [Full Text] [Related]
4. Established intraportal islet allograft is rejected despite the acceptance of donor-specific second cardiac allograft. Kamei T; Yasunami Y; Arima T; Ryu S; Ueki M; Konomi K Transplant Proc; 1992 Dec; 24(6):2885-6. PubMed ID: 1281579 [No Abstract] [Full Text] [Related]
6. Heterotopic liver transplantation in rats: effect of intrahepatic islet isografts and split portal blood flow on liver integrity after auxiliary liver isotransplantation. Yu W; Wan X; Wright JR; Coddington D; Bitter-Suermann H Surgery; 1994 Jan; 115(1):108-17. PubMed ID: 8284751 [TBL] [Abstract][Full Text] [Related]
7. Masking donor major histocompatibility complex class I antigens on allogeneic islets. Munn SR; Marjoribanks C Transplant Proc; 1992 Dec; 24(6):2857. PubMed ID: 1465973 [No Abstract] [Full Text] [Related]
8. Heterotopic hepatocyte transplantation using three-dimensional polymers: evaluation of the stimulatory effects by portacaval shunt or islet cell cotransplantation. Kaufmann PM; Sano K; Uyama S; Schloo B; Vacanti JP Transplant Proc; 1994 Dec; 26(6):3343-5. PubMed ID: 7998165 [No Abstract] [Full Text] [Related]
9. Treatment with anti-VLA-4 and LFA-1 monoclonal antibodies prolongs intraportal rat islet allograft survival. Yang H; Issekutz TB; Wright JR Transplant Proc; 1994 Dec; 26(6):3325-6. PubMed ID: 7998156 [No Abstract] [Full Text] [Related]
10. FK 506: an effective immunosuppressant for islet xenotransplantation. Tze WJ; Tai J; Cheung SS; Ricordi C; Starzl TE Transplant Proc; 1992 Dec; 24(6):2849-50. PubMed ID: 1281577 [No Abstract] [Full Text] [Related]
11. Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506. Yasunami Y; Ryu S; Ueki M; Arima T; Ikeda S; Kamei T Transplant Proc; 1994 Apr; 26(2):722. PubMed ID: 7513467 [No Abstract] [Full Text] [Related]
16. Primary nonfunction of porcine islets of Langerhans in the thymus of diabetic rats without immunosuppression. de Villa VH; Cienfuegos JA; Hernandez JL; Pardo F; Benito C; Balen E; Saez E; Alava E Transplant Proc; 1992 Dec; 24(6):2984-5. PubMed ID: 1466024 [No Abstract] [Full Text] [Related]
17. Prolongation of islet allograft survival is facilitated by storage conditions using cryopreservation involving fast cooling and/or tissue culture. Taylor MJ; Foreman J; Biwata Y; Tsukikawa S Transplant Proc; 1992 Dec; 24(6):2860-2. PubMed ID: 1465975 [No Abstract] [Full Text] [Related]
18. A new mouse model for intraportal islet transplantation with limited hepatic lobe as a graft site. Yonekawa Y; Okitsu T; Wake K; Iwanaga Y; Noguchi H; Nagata H; Liu X; Kobayashi N; Matsumoto S Transplantation; 2006 Sep; 82(5):712-5. PubMed ID: 16969298 [TBL] [Abstract][Full Text] [Related]